The Federal Health Agency is expected to expand research into potential treatments for autism spectrum disorder. A recent report from The Washington Post suggests the administration is also considering leucovorin, a form of folate, as a potential therapeutic option. This investigation follows previous research exploring the possible correlation between Tylenol and autism. Officials are reviewing data to determine if any established link exists and to assess the potential efficacy of these treatments. The agency’s focus includes exploring potential mechanisms and monitoring outcomes.
Credits: US Top News and Analysis
